Quoin Pharmaceuticals Ltd... (QNRX)
undefined
undefined%
At close: undefined
0.64
-3.52%
Pre-market Dec 16, 2024, 04:11 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -8.69M -9.38M -21.46M -2.10M -1.56M -5.59M -7.91M -4.00M -2.62M
Depreciation & Amortization 103.71K 104.04K 104.04K 104.04K 20.71K 125.72K 104.22K 89.13K 18.27K
Stock-Based Compensation 1.09M 764.01K - - - - - - -
Other Working Capital 41.42K 123.45K -18.68K 47.04K -466.74K 221.96K - - -
Other Non-Cash Items -471.31K 127.06K 14.31M 378.33K -512.77K -1.10M 2.54M 215.90K 134.59K
Deferred Income Tax - - - - - - - - -
Change in Working Capital 95.20K -94.35K 1.33M 274.36K 240.83K 233.92K 245.71K 54.89K 258.64K
Operating Cash Flow -7.86M -8.48M -5.72M -1.34M -1.30M -6.57M -4.98M -3.77M -1.98M
Capital Expenditures - -250.00K -625.00K -125.00K -123.00K -182.46K -74.53K -330.64K -85.44K
Acquisitions - - - - 1.68K - - 24.83K 19.82K
Purchase of Investments -18.09M -9.90M - - -4.21K -6.12K -2.57M -5.14M -
Sales Maturities Of Investments 20.28M 14.88B - - 2.53K 4.00M 5.47M 733.96K 882.71K
Other Investing Acitivies - -14.88B -625 -125 15.00K 3.83M 2.99M - -
Investing Cash Flow 2.19M -10.15M -625.00K -125.00K -108.00K 3.81M 2.83M -4.71M 817.09K
Debt Repayment - -311.67K 3.48M 909.98K - - - - -
Common Stock Repurchased - -14.82M - - - - - - -
Dividend Paid - -65.27M - - - - - - -
Other Financial Acitivies 5.22M 14.32M 10.03M 877.49K 1.30M - - - -
Financial Cash Flow 5.22M 14.01M 13.50M 1.79M 1.30M 3.55M 4.43M 9.13M 1.65M
Net Cash Flow -459.43K -4.62M 7.16M -4.92M 5.24M 809.83K 2.32M 653.45K 478.93K
Free Cash Flow -7.86M -8.73M -6.35M -1.46M -1.42M -6.76M -5.05M -4.10M -2.07M